Form D

View Original Filing

Notice of Exempt Offering of Securities

Item 1. Issuer's Identity

Name of Issuer:
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P.
Jurisdiction of Incorporation/Organization
CAYMAN ISLANDS
Year of Incorporation/Organization
2019

Previous Name(s)

Entity Type
OTHER

Item 2 Issuer Principal Place of Business and Contact Information

190 ELGIN AVENUE, GEORGE TOWN
GRAND CAYMAN, E9 KY1-9005
Phone Number: subscription required

Item 3. Related Persons

Name
-- WELLINGTON ALTERNATIVE INVESTMENTS LLC
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • PROMOTER
Clarification of Response
GENERAL PARTNER

Item 3. Related Persons

Name
-- WELLINGTON MANAGEMENT COMPANY LLP
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • PROMOTER
Clarification of Response
INVESTMENT MANAGER

Item 3. Related Persons

Name
-- WELLINGTON MANAGEMENT INVESTMENT, INC.
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response
MANAGING MEMBER OF THE GENERAL PARTNER

Item 4. Industry Group

POOLED INVESTMENT FUND - PRIVATE EQUITY FUND

Item 5. Issuer Size

Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE

Item 6. Federal Exemptions and Exclusions Claimed

Item 7. Type of Filing

New Notice
Date of First Sale in this Offering:
First Sale Yet to Occur

Item 8. Duration of Offering

Does the issuer intend this offering to last more than one year?
No

Item 9. Type(s) of Securities Offered

  • Equity
  • Pooled Investment Fund Interests

Item 10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response

Item 11. Minimum Investment

Minimum Investment accepted from any outside investor
0

Item 12. Sales Compensation

Recipient
CITIGROUP GLOBAL MARKETS INC.
Recipient CRD Number
7059
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
388 GREENWICH STREET
NEW YORK, NY 10013
States of Solicitation
  • ALL STATES

Item 12. Sales Compensation

Recipient
CITI PRIVATE ADVISORY, LLC
Recipient CRD Number
153777
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
388 GREENWICH STREET
NEW YORK, NY 10013
States of Solicitation
  • ALL STATES

Item 13. Offering and Sales Amounts

Total Offering Amount
INDEFINITE
Total Amount Sold
0
Total Remaining to be Sold
INDEFINITE
Clarification of Response

Item 14. Investors

Securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
0

Item 15. Sales Commissions and Finders' Fees Expenses

Sales Commissions:
0.0 Is an estimate
Finders' Fees
0.0 Is an estimate
Clarification of Response
THE RECIPIENTS LISTED IN ITEM 12 ARE PAID AN AMOUNT EQUAL TO A PERCENTAGE OF CERTAIN ASSETS UNDER MANAGEMENT.

Item 16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers,directors or promoters in response to Item 3 above.
0.0 Is an estimate
Clarification of Response

Signature and Submission

Issuer Name
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P.
Issuer Signature
J. COLIN SULLIVAN
Signer Name
J. COLIN SULLIVAN
Signer Title
VICE PRESIDENT OF THE GENERAL PARTNER
Signature Date
10/03/2019
WhaleWisdom Logo

Elevate your investments